Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Mar 17:8:21.
doi: 10.3389/fncir.2014.00021. eCollection 2014.

Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease

Affiliations
Review

Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease

Cristina Miguelez et al. Front Neural Circuits. .

Abstract

The neurotransmitter serotonin (5-HT) has a multifaceted function in the modulation of information processing through the activation of multiple receptor families, including G-protein-coupled receptor subtypes (5-HT1, 5-HT2, 5-HT4-7) and ligand-gated ion channels (5-HT3). The largest population of serotonergic neurons is located in the midbrain, specifically in the raphe nuclei. Although the medial and dorsal raphe nucleus (DRN) share common projecting areas, in the basal ganglia (BG) nuclei serotonergic innervations come mainly from the DRN. The BG are a highly organized network of subcortical nuclei composed of the striatum (caudate and putamen), subthalamic nucleus (STN), internal and external globus pallidus (or entopeduncular nucleus in rodents, GPi/EP and GPe) and substantia nigra (pars compacta, SNc, and pars reticulata, SNr). The BG are part of the cortico-BG-thalamic circuits, which play a role in many functions like motor control, emotion, and cognition and are critically involved in diseases such as Parkinson's disease (PD). This review provides an overview of serotonergic modulation of the BG at the functional level and a discussion of how this interaction may be relevant to treating PD and the motor complications induced by chronic treatment with L-DOPA.

Keywords: 5-HT; L-DOPA induced dyskinesia; Parkinson's disease; basal ganglia; electrophysiology.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Simplified diagram of the basal ganglia circuits and altered serotonergic receptor expression in pathological states. Changes found in serotonergic receptor density in parkinsonian (left boxes) and dyskinetic (right boxes) patients or animals models compared to control conditions. Each nucleus and its modifications in receptor expression are encoded with the same color. GABAergic inhibitory pathways are represented in dark blue and glutamatergic excitatory pathways in red. Modulatory dopaminergic connections are indicated in green and serotonergic pathways in brown. DRN, dorsal raphe nucleus; GPi (EP), internal segment of the globus pallidus (entopeduncular nucleus); GPe, external segment of the globus pallidus; STN, subthalamic nucleus; SNc, substantia nigra pars compacta; SNr, substantia nigra pars reticulata. r, rodent; m, monkey; h, human.

Similar articles

Cited by

References

    1. Abramowski D., Rigo M., Duc D., Hoyer D., Staufenbiel M. (1995). Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera. Neuropharmacology 34, 1635–1645 10.1016/0028-3908(95)00138-7 - DOI - PubMed
    1. Aguiar L. M., Macedo D. S., Vasconcelos S. M., Oliveira A. A., De Sousa F. C., Viana G. S. (2008). CSC, an adenosine A(2A) receptor antagonist and MAO B inhibitor, reverses behavior, monoamine neurotransmission, and amino acid alterations in the 6-OHDA-lesioned rats. Brain Res. 1191, 192–199 10.1016/j.brainres.2007.11.051 - DOI - PubMed
    1. Aguiar L. M., Nobre H. V., Jr., Macedo D. S., Oliveira A. A., Freitas R. M., Vasconcelos S. M., et al. (2006). Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats. Pharmacol. Biochem. Behav. 84, 415–419 10.1016/j.pbb.2006.05.027 - DOI - PubMed
    1. Antonelli T., Fuxe K., Tomasini M. C., Bartoszyk G. D., Seyfried C. A., Tanganelli S., et al. (2005). Effects of sarizotan on the corticostriatal glutamate pathways. Synapse 58, 193–199 10.1002/syn.20195 - DOI - PubMed
    1. Arai R., Karasawa N., Geffard M., Nagatsu I. (1995). L-DOPA is converted to dopamine in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study. Neurosci. Lett. 195, 195–198 10.1016/0304-3940(95)11817-G - DOI - PubMed

Publication types

MeSH terms